baicalin has been researched along with Fatty Liver in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, C; Chen, T; Chen, XW; Dai, J; Hou, X; Huang, Y; Jia, W; Liang, K; Liu, Y; Luo, T; Lv, J; Wang, C; Wang, YL; Wu, H; Xiao, J; Xiao, RP; Zhang, X; Zhao, S; Zhou, S; Zhuang, S | 1 |
Fan, Y; Han, X; Hu, C; Li, H; Wang, C; Wang, Y; Wen, C; Zhang, J; Zhang, S | 1 |
Dong, S; Gu, M; Jiang, Y; Li, H; Liu, H; Liu, Y; Luo, E; Shen, X; Wu, M; Xi, Y | 1 |
Du, ZY; Guo, HX; Liu, DH; Liu, JF; Ma, Y; Peng, HL; Shen, JK; Wang, X; Wang, Y | 1 |
4 other study(ies) available for baicalin and Fatty Liver
Article | Year |
---|---|
Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis.
Topics: Allosteric Regulation; Animals; Binding Sites; Carnitine O-Palmitoyltransferase; Diet; Enzyme Activation; Fatty Liver; Flavonoids; HeLa Cells; Humans; Liver; Mice; Mitochondria, Liver; Obesity; Proteomics | 2018 |
Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.
Topics: Animals; Dexamethasone; Fatty Liver; Flavonoids; Glucocorticoids; Idiopathic Pulmonary Fibrosis; Lipids; Liver Diseases; Male; Mice; Mice, Inbred ICR | 2015 |
Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway.
Topics: Acetyl-CoA Carboxylase; Adipose Tissue; Alanine Transaminase; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Diet, High-Fat; Fatty Liver; Flavonoids; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Signal Transduction; Triglycerides | 2015 |
Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dietary Fats; Dose-Response Relationship, Drug; Drug Delivery Systems; Fatty Liver; Flavonoids; Hep G2 Cells; Humans; Male; Metabolic Diseases; Phosphorylation; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Weight Gain | 2009 |